Encyclopedia of Medical Immunology

Living Edition
| Editors: Ian MacKay, Noel R. Rose

X-Linked Neutropenia/Myelodysplasia

  • Eli MansourEmail author
  • Denise Leite-Caldeira
Living reference work entry
DOI: https://doi.org/10.1007/978-1-4614-9209-2_138-1

Synonyms

Definition

X-linked neutropenia (OMIM #300299) is an X-linked form of severe non-syndromic congenital neutropenia, caused by mutation in the WASP gene (OMIM 300392) mapped to the short arm of the X chromosome, Xp11.23.

Introduction

X-linked neutropenia (XLN) is a rare severe congenital neutropenia (SCN) due to an activating mutation of WASP gene. As a result, the gene product Wiskott-Aldrich syndrome protein (WASP) is overactive. Mutations of the WASP gene are responsible for three distinct phenotypes: X-linked thrombocytopenia (XLT), classic Wiskott-Aldrich syndrome (WAS), and XLN. XLN is characterized by profound neutropenia, associated with monocytopenia and T lymphopenia, and an increased risk of myelodysplasia (MDS) and acute myeloid leukemia (AML). XLN is a rare cause of severe congenital neutropenias affecting about 2% of cases (Ochs 2009; Skokowa et al. 2017; Spoor et al. 2019).

Pathogenesis and...

This is a preview of subscription content, log in to check access.

References

  1. Dale DC. How I diagnose and treat neutropenia. Curr Opin Hematol. 2016;23:1–4.CrossRefGoogle Scholar
  2. Errante PR, Josias Brito Frazão JB, Condino Neto A. Congenital neutropenia. Braz J Allergy Immunol. 2013;1:23–38.Google Scholar
  3. Keszei M, Record J, Kritikou JS, et al. Constitutive activation of WASp in X-linked neutropenia renders neutrophils hyperactive. J Clin Invest. 2018;128:4115–31.CrossRefGoogle Scholar
  4. Kobayashi M, Yokoyama K, Shimizu E, et al. Phenotype-based gene analysis allowed successful diagnosis of X-linked neutropenia associated with a novel WASp mutation. Ann Hematol. 2018;97:367–9.CrossRefGoogle Scholar
  5. Kuruvilla M, de la Morena MT. Antibiotic prophylaxis in primary immune deficiency disorders. J Allergy Clin Immunol Pract. 2013;1:573–82.CrossRefGoogle Scholar
  6. Moulding DA, Moeendarbary E, Valon L, et al. Excess F-actin mechanically impedes mitosis leading to cytokinesis failure in X-linked neutropenia by exceeding Aurora B kinase error correction capacity. Blood. 2012;120:3803–11.CrossRefGoogle Scholar
  7. Ochs HD. Mutations of the Wiskott–Aldrich syndrome protein affect protein expression and dictate the clinical phenotypes. Immunol Res. 2009;44:84–8.CrossRefGoogle Scholar
  8. Oshima K, Imai K, Albert MH, Bittner TC, et al. Hematopoietic stem cell transplantation for X-linked thrombocytopenia with mutations in the WAS gene. J Clin Immunol. 2015;35:15–21.CrossRefGoogle Scholar
  9. Skokowa J, Dale DC, Touw IP, et al. Severe congenital neutropenias. Nat Rev Dis Primers. 2017;3:17032.CrossRefGoogle Scholar
  10. Sobh A, Bonilla FA. Vaccination in primary immunodeficiency disorders. J Allergy Clin Immunol Pract. 2016;4:1066–75.CrossRefGoogle Scholar
  11. Spoor J, Farajifard H, Rezaei N. Congenital neutropenia and primary immunodeficiency diseases. Crit Rev Oncol Hematol. 2019;133:149–62.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2020

Authors and Affiliations

  1. 1.Division of Clinical Immunology and Allergy, Department of Clinical MedicineState University of Campinas (UNICAMP)CampinasBrazil

Section editors and affiliations

  • Antonio Condino-Neto
    • 1
  1. 1.Department of ImmunologyInstitute of Biomedical Sciences – University of São PauloSão PauloBrazil